Tear Analysis in the Diagnosis of Multiple Sclerosis

NCT02016222 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2016-09-20

No results posted yet for this study

Summary

In the primary progressive multiple sclerosis, the detection of oligoclonal bands in cerebrospinal fluid is critical for the diagnosis. However, lumbar puncture for cerebrospinal fluid collection is considered relatively invasive. Our hypothesis is that oligoclonal bands detection in tears is possible and useful for the diagnosis of multiple sclerosis.

Conditions

Interventions

PROCEDURE

tears sampling

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY
  • Lille Catholic University

    lead OTHER

Principal Investigators

  • Patrick Hautecoeur, MD · Groupement des Hôpitaux de l'Institut Catholique de Lille (GHICL)

  • Elisabeth Baumelou, MD · Groupement des Hôpitaux de l'Institut Catholique de Lille

  • Patrick Vermersch, MD, PhD · Centre Hospitalier Régional, Universitaire de Lille

  • Christine Lebrun-Frenay, MD, PhD · Centre Hospitalier Universitaire de Nice

  • Jérome De Sèze, MD, PhD · Centre Hospitalier Régional Universitaire de Strasbourg

  • Thibaut Moreau, MD · Centre Hospitalier Universitaire Dijon

  • Pierre Clavelou, MD · Centre Hospitalier Régional Universitaire de Clermont-Ferrand

  • Olivier Heinzlef, MD · Centre hospitalier intercommunal de Poissy

  • Christian Confavreux, MD · Hospices Civils de Lyon

  • Marc Debouverie, MD, PhD · Central Hospital, Nancy, France

  • Jean Pelletier, MD, PhD · L'assistance Publique des Hôpitaux de Marseille

  • Bruno Brochet, MD, PhD · University Hospital, Bordeaux

  • Gilles Defer, MD · Centre Hospitalier Universitaire de Caen

  • Eric Thouvenot, MD · Centre Hospitalier Universitaire de Nîmes

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02016222 on ClinicalTrials.gov